USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

Show other versions (1)

Haematological abnormalities are common during combination antiviral therapy for chronic hepatitis C. Although dose reduction or discontinuation can easily treat these side effects, they can adversely affect the efficacy of combination antiviral therapy reducing the likelihood of a sustained viral r...

Full description

Bibliographic Details
Main Authors: Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet
Format: Article
Language:English
Published: Mattioli1885 2010-03-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Hepatitis
Thrombocytopenia
Interferon
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/159

Internet

http://www.mjhid.org/index.php/mjhid/article/view/159

Similar Items